↓ Skip to main content

Huntington’s Disease

Overview of attention for book
Huntington’s Disease
Springer New York

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Stereological Methods to Quantify Cell Loss in the Huntington’s Disease Human Brain
  3. Altmetric Badge
    Chapter 2 Assessing Autophagic Activity and Aggregate Formation of Mutant Huntingtin in Mammalian Cells
  4. Altmetric Badge
    Chapter 3 A Filter Retardation Assay Facilitates the Detection and Quantification of Heat-Stable, Amyloidogenic Mutant Huntingtin Aggregates in Complex Biosamples
  5. Altmetric Badge
    Chapter 4 Cellular Models: HD Patient-Derived Pluripotent Stem Cells
  6. Altmetric Badge
    Chapter 6 Mouse Models of Huntington’s Disease
  7. Altmetric Badge
    Chapter 8 Automated Operant Assessments of Huntington’s Disease Mouse Models
  8. Altmetric Badge
    Chapter 10 Murine Models of Huntington’s Disease for Evaluating Therapeutics
  9. Altmetric Badge
    Chapter 11 Generating Excitotoxic Lesion Models of Huntington’s Disease
  10. Altmetric Badge
    Chapter 12 Large-Brained Animal Models of Huntington’s Disease: Sheep
  11. Altmetric Badge
    Chapter 14 Nonhuman Primate Models of Huntington’s Disease and Their Application in Translational Research
  12. Altmetric Badge
    Chapter 15 In Vivo Multidimensional Brain Imaging in Huntington’s Disease Animal Models
  13. Altmetric Badge
    Chapter 16 Magnetic Resonance Imaging in Huntington’s Disease
  14. Altmetric Badge
    Chapter 17 Biofluid Biomarkers in Huntington’s Disease
  15. Altmetric Badge
    Chapter 18 Assessing and Modulating Kynurenine Pathway Dynamics in Huntington’s Disease: Focus on Kynurenine 3-Monooxygenase
  16. Altmetric Badge
    Chapter 20 Using Genomic Data to Find Disease-Modifying Loci in Huntington’s Disease (HD)
  17. Altmetric Badge
    Chapter 22 Methods for Assessing DNA Repair and Repeat Expansion in Huntington’s Disease
  18. Altmetric Badge
    Chapter 23 Translating Antisense Technology into a Treatment for Huntington’s Disease
  19. Altmetric Badge
    Chapter 26 Dissection and Preparation of Human Primary Fetal Ganglionic Eminence Tissue for Research and Clinical Applications
  20. Altmetric Badge
    Chapter 28 Quality Assessment and Production of Human Cells for Clinical Use
  21. Altmetric Badge
    Chapter 29 Erratum to: Large-Brained Animal Models of Huntington’s Disease: Sheep
Attention for Chapter: Robust Induction of DARPP32-Expressing GABAergic Striatal Neurons from Human Pluripotent Stem Cells
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Robust Induction of DARPP32-Expressing GABAergic Striatal Neurons from Human Pluripotent Stem Cells
Book title
Huntington’s Disease
Published in
Methods in molecular biology, January 2018
DOI 10.1007/978-1-4939-7825-0_27
Pubmed ID
Book ISBNs
978-1-4939-7824-3, 978-1-4939-7825-0
Authors

Marija Fjodorova, Meng Li

Abstract

Efficient generation of disease relevant neuronal subtypes from human pluripotent stem cells (PSCs) is fundamental for realizing their promise in disease modeling, pharmaceutical drug screening and cell therapy. Here we describe a step-by-step protocol for directing the differentiation of human embryonic and induced PSCs (hESCs and hiPSCs, respectively) toward medium spiny neurons, the type of cells that are preferentially lost in Huntington's disease patients. This method is based on a novel concept of Activin A-dependent induction of the lateral ganglionic/striatal fate using a simple monolayer culture paradigm under chemically defined conditions. Transplantable medium spiny neuron progenitors amenable for cryopreservation are produced in less than 20 days, which differentiate and mature into a high yield of dopamine- and cAMP-regulated phosphoprotein, Mr 32 kDa (DARPP32) expressing gamma-aminobutyric acid (GABA)-ergic neurons in vitro and in the adult rat brain after transplantation. This method has been validated in multiple hESC and hiPSC lines, and is independent of the regime for PSC maintenance.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 26%
Student > Ph. D. Student 5 22%
Student > Master 2 9%
Student > Bachelor 2 9%
Unspecified 1 4%
Other 2 9%
Unknown 5 22%
Readers by discipline Count As %
Neuroscience 5 22%
Agricultural and Biological Sciences 3 13%
Biochemistry, Genetics and Molecular Biology 2 9%
Medicine and Dentistry 2 9%
Unspecified 1 4%
Other 3 13%
Unknown 7 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 June 2018.
All research outputs
#15,532,144
of 23,083,773 outputs
Outputs from Methods in molecular biology
#5,409
of 13,205 outputs
Outputs of similar age
#270,117
of 442,605 outputs
Outputs of similar age from Methods in molecular biology
#596
of 1,499 outputs
Altmetric has tracked 23,083,773 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,205 research outputs from this source. They receive a mean Attention Score of 3.4. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,605 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,499 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.